Cap-Rouge, Canada

Marie-Claude Helie


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marie-Claude Helie: Innovator in Bacterial Mass Production of Taxanes

Introduction

Marie-Claude Helie is a prominent inventor based in Cap-Rouge, Canada. She has made significant contributions to the field of biotechnology, particularly in the production of taxanes and paclitaxel through innovative bacterial methods. Her work has the potential to impact the pharmaceutical industry by providing more efficient ways to produce these important compounds.

Latest Patents

Marie-Claude Helie holds a patent for her invention titled "Bacterial mass production of taxanes and paclitaxel." This patent describes a method for obtaining biologically pure cultures of bacteria isolated from various species of Taxus, including Taxus canadensis, T. brevifolia, T. baccata, T. cuspidata, and T. hunnewelliana. The bacteria, which belong to the genera Sphingomonas, Bacillus, Pantoea, or Curtobacterium, are capable of producing taxanes and paclitaxel in vitro. The invention also includes a process for improving the production of these compounds by culturing bacteria in the presence of a mutagenic agent, leading to the development of new mutated bacteria with enhanced yields of pro-taxane biotransformation.

Career Highlights

Throughout her career, Marie-Claude Helie has focused on the intersection of microbiology and pharmacology. Her innovative approaches have garnered attention in the scientific community, and her work continues to pave the way for advancements in the production of valuable pharmaceutical compounds.

Collaborations

Marie-Claude collaborates with Michel Page, who is also involved in the research and development of biotechnological solutions. Their partnership enhances the potential for breakthroughs in the field.

Conclusion

Marie-Claude Helie's contributions to the field of biotechnology, particularly in the bacterial mass production of taxanes and paclitaxel, highlight her innovative spirit and dedication to advancing pharmaceutical production methods. Her work is a testament to the importance of research and collaboration in driving scientific progress.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…